Bridion 200 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQS6R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,204
Award facts
- Contract value 100% obligated
- $38,203.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $38,203.98 for Bridion 200 mg/2 ml vials on December 19, 2025, with completion scheduled for December 22, 2025. This firm fixed price contract represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Bridion (sugammadex) is a neuromuscular blocking agent reversal medication used in surgical and anesthetic procedures to rapidly reverse the effects of certain muscle relaxants.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare systems worldwide. The company serves as a key federal vendor for the Defense Health Agency and other government healthcare organizations through this flexible contracting vehicle designed to meet diverse pharmaceutical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQS6R?
SPE2DR26FQS6R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FQS6R worth?
The government has obligated $38,204 on SPE2DR26FQS6R.
Is contract SPE2DR26FQS6R an order under another contract?
Yes. SPE2DR26FQS6R is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS6R competed?
The extent of competition for SPE2DR26FQS6R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award